APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mucopolysaccharidosis II

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mucopolysaccharidosis II Industry Growth and Trends Forecast to 2032

Report ID 174014750126 December 2025109 pages

Choose your research edition.

Industry ResearchMucopolysaccharidosis II Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Mucopolysaccharidosis II Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mucopolysaccharidosis II Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mucopolysaccharidosis II Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mucopolysaccharidosis II Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mucopolysaccharidosis II market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mucopolysaccharidosis II is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mucopolysaccharidosis II include Takeda, Sangamo BioSciences, Inc., RegenxBio Inc., Laboratorios Del Dr. Esteve S.A., JCR Pharmaceuticals Co., Ltd., Inventiva, Green Cross Corporation, Bioasis Technologies Inc. and ArmaGen Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mucopolysaccharidosis II market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mucopolysaccharidosis II market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mucopolysaccharidosis II market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mucopolysaccharidosis II.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mucopolysaccharidosis II market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mucopolysaccharidosis II Market by Company

Takeda

Sangamo BioSciences, Inc.

RegenxBio Inc.

Laboratorios Del Dr. Esteve S.A.

JCR Pharmaceuticals Co., Ltd.

Inventiva

Green Cross Corporation

Bioasis Technologies Inc.

ArmaGen Inc.

AngioChem Inc.

Alexion Pharmaceuticals, Inc.

Mucopolysaccharidosis II Segment by Type

AGT-182

DUOC-01

EGT-301

JR-032

JR-141

Others

Mucopolysaccharidosis II Segment by Application

Clinic

Hospital

Research Center

Others

Mucopolysaccharidosis II Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mucopolysaccharidosis II market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mucopolysaccharidosis II and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mucopolysaccharidosis II.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mucopolysaccharidosis II in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AGT-182 Table 2. Major Company of DUOC-01 Table 3. Major Company of EGT-301 Table 4. Major Company of JR-032 Table 5. Major Company of JR-141 Table 6. Major Company of Others Table 7. Global Mucopolysaccharidosis II Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 9. Global Mucopolysaccharidosis II Sales Market Share in Volume by Type (2021-2026) Table 10. Global Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 11. Global Mucopolysaccharidosis II Sales Market Share in Value by Type (2021-2026) Table 12. Global Mucopolysaccharidosis II Price by Type (2021-2026) & (US$/Unit) Table 13. Global Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 14. Global Mucopolysaccharidosis II Sales Market Share in Volume by Type (2027-2032) Table 15. Global Mucopolysaccharidosis II Sales by Type (2027-2032) & (US$ Million) Table 16. Global Mucopolysaccharidosis II Sales Market Share in Value by Type (2027-2032) Table 17. Global Mucopolysaccharidosis II Price by Type (2027-2032) & (US$/Unit) Table 18. North America Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 19. North America Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 21. Europe Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 25. Latin America Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Mucopolysaccharidosis II Sales by Type (2021-2026) & (US$ Million) Table 28. Mucopolysaccharidosis II Industry Trends Table 29. Mucopolysaccharidosis II Industry Drivers Table 30. Mucopolysaccharidosis II Industry Opportunities and Challenges Table 31. Mucopolysaccharidosis II Industry Restraints Table 32. Global Mucopolysaccharidosis II Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Mucopolysaccharidosis II Revenue Market Share by Company (2021-2026) Table 34. Global Mucopolysaccharidosis II Sales by Company (2021-2026) & (W Units) Table 35. Global Mucopolysaccharidosis II Sales Share by Company (2021-2026) Table 36. Global Mucopolysaccharidosis II Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Mucopolysaccharidosis II Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Mucopolysaccharidosis II Major Company Production Sites and Headquarters Table 39. Global Mucopolysaccharidosis II Company, Product Type & Application Table 40. Global Mucopolysaccharidosis II Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Mucopolysaccharidosis II Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Mucopolysaccharidosis II Sales by Region (2021-2026) & (W Units) Table 45. Global Mucopolysaccharidosis II Sales Market Share in Volume by Region (2021-2026) Table 46. Global Mucopolysaccharidosis II Sales by Region (2021-2026) & (US$ Million) Table 47. Global Mucopolysaccharidosis II Sales Market Share in Value by Region (2021-2026) Table 48. Global Mucopolysaccharidosis II Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Mucopolysaccharidosis II Sales by Region (2027-2032) & (W Units) Table 50. Global Mucopolysaccharidosis II Sales Market Share in Volume by Region (2027-2032) Table 51. Global Mucopolysaccharidosis II Sales by Region (2027-2032) & (US$ Million) Table 52. Global Mucopolysaccharidosis II Sales Market Share in Value by Region (2027-2032) Table 53. Global Mucopolysaccharidosis II Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Mucopolysaccharidosis II Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 56. Global Mucopolysaccharidosis II Sales Market Share in Volume by Application (2021-2026) Table 57. Global Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 58. Global Mucopolysaccharidosis II Sales Market Share in Value by Application (2021-2026) Table 59. Global Mucopolysaccharidosis II Price by Application (2021-2026) & (US$/Unit) Table 60. Global Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 61. Global Mucopolysaccharidosis II Sales Market Share in Volume by Application (2027-2032) Table 62. Global Mucopolysaccharidosis II Sales by Application (2027-2032) & (US$ Million) Table 63. Global Mucopolysaccharidosis II Sales Market Share in Value by Application (2027-2032) Table 64. Global Mucopolysaccharidosis II Price by Application (2027-2032) & (US$/Unit) Table 65. North America Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 66. North America Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 68. Europe Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 72. Latin America Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2021-2026) & (US$ Million) Table 75. Takeda Company Information Table 76. Takeda Business Overview Table 77. Takeda Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Takeda Mucopolysaccharidosis II Product Portfolio Table 79. Takeda Recent Development Table 80. Sangamo BioSciences, Inc. Company Information Table 81. Sangamo BioSciences, Inc. Business Overview Table 82. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio Table 84. Sangamo BioSciences, Inc. Recent Development Table 85. RegenxBio Inc. Company Information Table 86. RegenxBio Inc. Business Overview Table 87. RegenxBio Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio Table 89. RegenxBio Inc. Recent Development Table 90. Laboratorios Del Dr. Esteve S.A. Company Information Table 91. Laboratorios Del Dr. Esteve S.A. Business Overview Table 92. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio Table 94. Laboratorios Del Dr. Esteve S.A. Recent Development Table 95. JCR Pharmaceuticals Co., Ltd. Company Information Table 96. JCR Pharmaceuticals Co., Ltd. Business Overview Table 97. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio Table 99. JCR Pharmaceuticals Co., Ltd. Recent Development Table 100. Inventiva Company Information Table 101. Inventiva Business Overview Table 102. Inventiva Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Inventiva Mucopolysaccharidosis II Product Portfolio Table 104. Inventiva Recent Development Table 105. Green Cross Corporation Company Information Table 106. Green Cross Corporation Business Overview Table 107. Green Cross Corporation Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Green Cross Corporation Mucopolysaccharidosis II Product Portfolio Table 109. Green Cross Corporation Recent Development Table 110. Bioasis Technologies Inc. Company Information Table 111. Bioasis Technologies Inc. Business Overview Table 112. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio Table 114. Bioasis Technologies Inc. Recent Development Table 115. ArmaGen Inc. Company Information Table 116. ArmaGen Inc. Business Overview Table 117. ArmaGen Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio Table 119. ArmaGen Inc. Recent Development Table 120. AngioChem Inc. Company Information Table 121. AngioChem Inc. Business Overview Table 122. AngioChem Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. AngioChem Inc. Mucopolysaccharidosis II Product Portfolio Table 124. AngioChem Inc. Recent Development Table 125. Alexion Pharmaceuticals, Inc. Company Information Table 126. Alexion Pharmaceuticals, Inc. Business Overview Table 127. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio Table 129. Alexion Pharmaceuticals, Inc. Recent Development Table 130. North America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. North America Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 132. North America Mucopolysaccharidosis II Sales Market Share by Country (2021-2026) Table 133. North America Mucopolysaccharidosis II Sales Forecast by Country (2027-2032) & (W Units) Table 134. North America Mucopolysaccharidosis II Sales Market Share Forecast by Country (2027-2032) Table 135. North America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Mucopolysaccharidosis II Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Mucopolysaccharidosis II Market Share by Country (2021-2026) Table 138. North America Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Mucopolysaccharidosis II Market Share Forecast by Country (2027-2032) Table 140. Europe Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Europe Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 142. Europe Mucopolysaccharidosis II Sales Market Share by Country (2021-2026) Table 143. Europe Mucopolysaccharidosis II Sales Forecast by Country (2027-2032) & (W Units) Table 144. Europe Mucopolysaccharidosis II Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Mucopolysaccharidosis II Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Mucopolysaccharidosis II Market Share by Country (2021-2026) Table 148. Europe Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Mucopolysaccharidosis II Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 152. Asia-Pacific Mucopolysaccharidosis II Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Mucopolysaccharidosis II Sales Forecast by Country (2027-2032) & (W Units) Table 154. Asia-Pacific Mucopolysaccharidosis II Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Mucopolysaccharidosis II Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Mucopolysaccharidosis II Market Share by Country (2021-2026) Table 158. Asia-Pacific Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Mucopolysaccharidosis II Market Share Forecast by Country (2027-2032) Table 160. Latin America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Latin America Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 162. Latin America Mucopolysaccharidosis II Sales Market Share by Country (2021-2026) Table 163. Latin America Mucopolysaccharidosis II Sales Forecast by Country (2027-2032) & (W Units) Table 164. Latin America Mucopolysaccharidosis II Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Mucopolysaccharidosis II Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Mucopolysaccharidosis II Market Share by Country (2021-2026) Table 168. Latin America Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Mucopolysaccharidosis II Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 172. Middle East and Africa Mucopolysaccharidosis II Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Mucopolysaccharidosis II Sales Forecast by Country (2027-2032) & (W Units) Table 174. Middle East and Africa Mucopolysaccharidosis II Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Mucopolysaccharidosis II Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Mucopolysaccharidosis II Market Share by Country (2021-2026) Table 178. Middle East and Africa Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Mucopolysaccharidosis II Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Mucopolysaccharidosis II Distributors List Table 183. Mucopolysaccharidosis II Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Mucopolysaccharidosis II Image Figure 2. Global Mucopolysaccharidosis II Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mucopolysaccharidosis II Market Size (2021-2032) & (US$ Million) Figure 4. Global Mucopolysaccharidosis II Sales (2021-2032) & (W Units) Figure 5. AGT-182 Image Figure 6. Global AGT-182 Sales YoY Growth (2021-2032) & (W Units) Figure 7. DUOC-01 Image Figure 8. Global DUOC-01 Sales YoY Growth (2021-2032) & (W Units) Figure 9. EGT-301 Image Figure 10. Global EGT-301 Sales YoY Growth (2021-2032) & (W Units) Figure 11. JR-032 Image Figure 12. Global JR-032 Sales YoY Growth (2021-2032) & (W Units) Figure 13. JR-141 Image Figure 14. Global JR-141 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Mucopolysaccharidosis II Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Mucopolysaccharidosis II Market Share by Type 2025 VS 2032 Figure 19. North America Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2025 Figure 20. North America Mucopolysaccharidosis II Sales Market Share in Value by Type in 2025 Figure 21. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2025 Figure 22. Europe Mucopolysaccharidosis II Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Type in 2025 Figure 25. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Mucopolysaccharidosis II Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 35. Research Center Image Figure 36. Global Research Center Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Mucopolysaccharidosis II Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Mucopolysaccharidosis II Market Share by Application 2025 VS 2032 Figure 41. North America Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2025 Figure 42. North America Mucopolysaccharidosis II Sales Market Share in Value by Application in 2025 Figure 43. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2025 Figure 44. Europe Mucopolysaccharidosis II Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Application in 2025 Figure 47. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Application in 2025 Figure 51. North America Mucopolysaccharidosis II Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Mucopolysaccharidosis II Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Mucopolysaccharidosis II Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Mucopolysaccharidosis II Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Mucopolysaccharidosis II Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Mucopolysaccharidosis II Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Mucopolysaccharidosis II Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Mucopolysaccharidosis II Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Mucopolysaccharidosis II Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Mucopolysaccharidosis II Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mucopolysaccharidosis II Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Mucopolysaccharidosis II Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Mucopolysaccharidosis II Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Mucopolysaccharidosis II Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Mucopolysaccharidosis II Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Mucopolysaccharidosis II Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Mucopolysaccharidosis II Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Mucopolysaccharidosis II Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Mucopolysaccharidosis II Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Mucopolysaccharidosis II Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Mucopolysaccharidosis II Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Mucopolysaccharidosis II Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • AGT-182
  • DUOC-01
  • EGT-301
  • JR-032
  • JR-141
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Takeda
  • Sangamo BioSciences, Inc.
  • RegenxBio Inc.
  • Laboratorios Del Dr. Esteve S.A.
  • JCR Pharmaceuticals Co., Ltd.
  • Inventiva
  • Green Cross Corporation
  • Bioasis Technologies Inc.
  • ArmaGen Inc.
  • AngioChem Inc.
  • Alexion Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mucopolysaccharidosis II Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mucopolysaccharidosis II Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mucopolysaccharidosis II Market by Type
  6. 1.3.1 AGT-182
  7. 1.3.2 DUOC-01
  8. 1.3.3 EGT-301
  9. 1.3.4 JR-032
  10. 1.3.5 JR-141
  11. 1.3.6 Others
  12. 1.4 Global Mucopolysaccharidosis II Market Size by Type
  13. 1.4.1 Global Mucopolysaccharidosis II Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Mucopolysaccharidosis II Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Mucopolysaccharidosis II Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Mucopolysaccharidosis II Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Mucopolysaccharidosis II Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Mucopolysaccharidosis II Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mucopolysaccharidosis II Industry Trends
  2. 2.2 Mucopolysaccharidosis II Industry Drivers
  3. 2.3 Mucopolysaccharidosis II Industry Opportunities and Challenges
  4. 2.4 Mucopolysaccharidosis II Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mucopolysaccharidosis II Revenue (2021-2026)
  2. 3.2 Global Top Players by Mucopolysaccharidosis II Sales (2021-2026)
  3. 3.3 Global Top Players by Mucopolysaccharidosis II Price (2021-2026)
  4. 3.4 Global Mucopolysaccharidosis II Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mucopolysaccharidosis II Major Company Production Sites & Headquarters
  6. 3.6 Global Mucopolysaccharidosis II Company, Product Type & Application
  7. 3.7 Global Mucopolysaccharidosis II Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mucopolysaccharidosis II Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mucopolysaccharidosis II Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mucopolysaccharidosis II Tier 1, Tier 2, and Tier 3
4 Mucopolysaccharidosis II Regional Status and Outlook
  1. 4.1 Global Mucopolysaccharidosis II Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mucopolysaccharidosis II Historic Market Size by Region
  3. 4.2.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mucopolysaccharidosis II Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mucopolysaccharidosis II Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mucopolysaccharidosis II Forecasted Market Size by Region
  7. 4.3.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mucopolysaccharidosis II Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mucopolysaccharidosis II Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mucopolysaccharidosis II by Application
  1. 5.1 Mucopolysaccharidosis II Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Center
  5. 5.1.4 Others
  6. 5.2 Global Mucopolysaccharidosis II Market Size by Application
  7. 5.2.1 Global Mucopolysaccharidosis II Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Mucopolysaccharidosis II Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Mucopolysaccharidosis II Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Mucopolysaccharidosis II Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Mucopolysaccharidosis II Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Mucopolysaccharidosis II Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Mucopolysaccharidosis II Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sangamo BioSciences, Inc.
  8. 6.2.1 Sangamo BioSciences, Inc. Company Information
  9. 6.2.2 Sangamo BioSciences, Inc. Business Overview
  10. 6.2.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio
  12. 6.2.5 Sangamo BioSciences, Inc. Recent Developments
  13. 6.3 RegenxBio Inc.
  14. 6.3.1 RegenxBio Inc. Company Information
  15. 6.3.2 RegenxBio Inc. Business Overview
  16. 6.3.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio
  18. 6.3.5 RegenxBio Inc. Recent Developments
  19. 6.4 Laboratorios Del Dr. Esteve S.A.
  20. 6.4.1 Laboratorios Del Dr. Esteve S.A. Company Information
  21. 6.4.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  22. 6.4.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio
  24. 6.4.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  25. 6.5 JCR Pharmaceuticals Co., Ltd.
  26. 6.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
  27. 6.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
  28. 6.5.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio
  30. 6.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
  31. 6.6 Inventiva
  32. 6.6.1 Inventiva Company Information
  33. 6.6.2 Inventiva Business Overview
  34. 6.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Inventiva Mucopolysaccharidosis II Product Portfolio
  36. 6.6.5 Inventiva Recent Developments
  37. 6.7 Green Cross Corporation
  38. 6.7.1 Green Cross Corporation Company Information
  39. 6.7.2 Green Cross Corporation Business Overview
  40. 6.7.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Green Cross Corporation Mucopolysaccharidosis II Product Portfolio
  42. 6.7.5 Green Cross Corporation Recent Developments
  43. 6.8 Bioasis Technologies Inc.
  44. 6.8.1 Bioasis Technologies Inc. Company Information
  45. 6.8.2 Bioasis Technologies Inc. Business Overview
  46. 6.8.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio
  48. 6.8.5 Bioasis Technologies Inc. Recent Developments
  49. 6.9 ArmaGen Inc.
  50. 6.9.1 ArmaGen Inc. Company Information
  51. 6.9.2 ArmaGen Inc. Business Overview
  52. 6.9.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio
  54. 6.9.5 ArmaGen Inc. Recent Developments
  55. 6.10 AngioChem Inc.
  56. 6.10.1 AngioChem Inc. Company Information
  57. 6.10.2 AngioChem Inc. Business Overview
  58. 6.10.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AngioChem Inc. Mucopolysaccharidosis II Product Portfolio
  60. 6.10.5 AngioChem Inc. Recent Developments
  61. 6.11 Alexion Pharmaceuticals, Inc.
  62. 6.11.1 Alexion Pharmaceuticals, Inc. Company Information
  63. 6.11.2 Alexion Pharmaceuticals, Inc. Business Overview
  64. 6.11.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio
  66. 6.11.5 Alexion Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Mucopolysaccharidosis II Sales by Country
  2. 7.1.1 North America Mucopolysaccharidosis II Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mucopolysaccharidosis II Sales by Country (2021-2026)
  4. 7.1.3 North America Mucopolysaccharidosis II Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mucopolysaccharidosis II Market Size by Country
  6. 7.2.1 North America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mucopolysaccharidosis II Market Size by Country (2021-2026)
  8. 7.2.3 North America Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mucopolysaccharidosis II Sales by Country
  2. 8.1.1 Europe Mucopolysaccharidosis II Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mucopolysaccharidosis II Sales by Country (2021-2026)
  4. 8.1.3 Europe Mucopolysaccharidosis II Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mucopolysaccharidosis II Market Size by Country
  6. 8.2.1 Europe Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mucopolysaccharidosis II Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mucopolysaccharidosis II Sales by Country
  2. 9.1.1 Asia-Pacific Mucopolysaccharidosis II Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mucopolysaccharidosis II Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mucopolysaccharidosis II Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mucopolysaccharidosis II Market Size by Country
  6. 9.2.1 Asia-Pacific Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mucopolysaccharidosis II Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mucopolysaccharidosis II Sales by Country
  2. 10.1.1 South America Mucopolysaccharidosis II Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mucopolysaccharidosis II Sales by Country (2021-2026)
  4. 10.1.3 South America Mucopolysaccharidosis II Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mucopolysaccharidosis II Market Size by Country
  6. 10.2.1 South America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mucopolysaccharidosis II Market Size by Country (2021-2026)
  8. 10.2.3 South America Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mucopolysaccharidosis II Sales by Country
  2. 11.1.1 Middle East and Africa Mucopolysaccharidosis II Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mucopolysaccharidosis II Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mucopolysaccharidosis II Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mucopolysaccharidosis II Market Size by Country
  6. 11.2.1 Middle East and Africa Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mucopolysaccharidosis II Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mucopolysaccharidosis II Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mucopolysaccharidosis II Value Chain Analysis
  2. 12.1.1 Mucopolysaccharidosis II Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mucopolysaccharidosis II Production Mode & Process
  7. 12.2 Mucopolysaccharidosis II Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mucopolysaccharidosis II Distributors
  10. 12.2.3 Mucopolysaccharidosis II Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst